DMK PHARMACEUTICALS CORP (DMK)

US00547W3079 - Common Stock

0.232  +0 (+0.91%)

After market: 0.1665 -0.07 (-28.23%)

News Image
7 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!

News Image
7 months ago - Seeking Alpha

DMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket (NASDAQ:DMK)

DMK Pharmaceuticals files for Chapter 11 bankruptcy, expecting court approval. Pre-market stock falls by 20.90%.

News Image
8 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic this morning as we check out all of the winners and losers worth keeping tabs on for Thursday!

News Image
9 months ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

Company seeking commercialization partnerships in the United States, Canada, and Europe to expand revenue generation...

News Image
10 months ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update

Now seeking out license opportunities for SYMJEPI®...

News Image
10 months ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Rebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid...

News Image
10 months ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on...

News Image
10 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning!

News Image
a year ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial-stage biopharmaceutical company, today announced...

News Image
a year ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial-stage biopharmaceutical company, today announced...

News Image
a year ago - DMK Pharmaceuticals Corporation

DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth

Seth Cohen is appointed Chief Financial Officer, bringing over thirty years of financial industry experience to DMK, and seasoned corporate lawyer John...

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are worth checking out on Monday as we start off the week with all the latest news this morning!

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!